Skip to results

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 276 to 300 of 2379

Published guidance, NICE advice and quality standards
TitleReference numberPublishedLast updated
Trabeculectomy with a biodegradable collagen matrix implant for glaucomaIPG750
Ambu aScope 4 Broncho for routine diagnostic and therapeutic bronchoscopyMIB314
Tobacco: preventing uptake, promoting quitting and treating dependenceNG209
Angiotensin II for treating vasosuppressor-resistant hypotension caused by septic or distributive shock (terminated appraisal)TA859
Disabled children and young people up to 25 with severe complex needs: integrated service delivery and organisation across health, social care and educationNG213
MRI-based technologies for assessing non-alcoholic fatty liver diseaseDG50
Laparoscopic insertion of a magnetic ring for gastro-oesophageal reflux diseaseIPG749
Transcutaneous electrical stimulation of the trigeminal nerve for ADHDIPG748
Nivolumab with platinum- and fluoropyrimidine-based chemotherapy for untreated HER2-negative advanced gastric, gastro-oesophageal junction or oesophageal adenocarcinomaTA857
Lenvatinib with pembrolizumab for untreated advanced renal cell carcinomaTA858
PredictSURE IBD for inflammatory bowel disease prognosis: ulcerative colitisMIB313
Diabetes in pregnancyQS109
Chronic heart failure in adultsQS9
Hip fracture: managementCG124
Hip fracture in adultsQS16
Percutaneous image-guided cryoablation of peripheral neuroma for chronic painIPG747
Upadacitinib for treating moderately to severely active ulcerative colitisTA856
Thyroid cancer: assessment and managementNG230
Tobacco: treating dependenceQS207
Avatrombopag for treating primary chronic immune thrombocytopeniaTA853
Fetal monitoring in labourNG229
Cabozantinib for previously treated advanced hepatocellular carcinomaTA849
Amivantamab for treating EGFR exon 20 insertion mutation-positive advanced non-small-cell lung cancer after platinum-based chemotherapyTA850
Pembrolizumab for neoadjuvant and adjuvant treatment of triple-negative early or locally advanced breast cancerTA851
Trifluridine–tipiracil for treating metastatic gastric cancer or gastro-oesophageal junction adenocarcinoma after 2 or more treatmentsTA852

Results per page

  1. 10
  2. 25
  3. 50
  4. All